PT-141 2mg — Vial Spec, Reconstitution Math & COA

PT-141 2mg Lyophilized Vial Overview & Target Applications

A 2mg lyophilized vial of PT-141 contains precisely 2.0 milligrams of high-purity Bremelanotide acetate, a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (α-MSH). In preclinical laboratory settings, the 2mg unit size serves as an ideal baseline quantity for single-assay runs, acute receptor-binding studies, or initial concentration-response testing. By utilizing a lower mass vial, research teams minimize potential degradation associated with repeated freeze-thaw cycles and prolonged storage of reconstituted peptide solutions.

Primary investigators order 2mg PT-141 vials specifically when experimental designs call for low total volume requirements, such as in vitro receptor binding affinity assays, localized tissue bath micro-perfusions, or short-term rodent cohort pilot runs. While PX1 Research standardly stocks high-capacity 10mg PT-141 vials to accommodate large-scale longitudinal research programs, understanding the 2mg unit mathematics is vital for bench researchers scaling their protocols across our catalog of research peptides.

The physical contents of a 2mg vial include the active peptide cake alongside a minimal mannitol or glycine lyoprotectant matrix. This formulation ensures rapid dissolution upon diluent introduction while preserving tertiary peptide structure during lyophilization and shipping. All unit sizes are produced under ISO 17025 laboratory conditions, sealed under inert nitrogen atmosphere, and fitted with color-coded flip-off aluminum seals to maintain sterile, moisture-free conditions prior to reconstituted laboratory use.

Melanocortin Receptor Signaling & Preclinical Targets

PT-141 functions as a non-selective, potent melanocortin receptor agonist, exhibiting primary binding activity at the melanocortin-3 receptor (MC3R) and melanocortin-4 receptor (MC4R) subtypes, with secondary affinity for MC1R and MC5R. Unlike classical peripherally acting vasoactive compounds, PT-141 acts directly within the central nervous system (CNS), specifically binding to receptors located in the hypothalamus, paraventricular nucleus (PVN), and medial preoptic area (mPOA).

In preclinical models, PT-141 has been extensively investigated for melanocortin-receptor signaling linked to central sexual-health pathways, neuro-endocrine modulation, and behavioral response cascades. In vitro assays demonstrate that binding to MC4R initiates intracellular cyclic adenosine monophosphate (cAMP) accumulation via G-protein coupled receptor (GPCR) activation. Rodent studies indicate that central administration of PT-141 triggers downstream neuronal firing in hypothalamic circuits, making it a critical reference compound for mapping central autonomic control.

Because PT-141 bypasses vascular endothelial mechanisms, preclinical studies suggest its primary utility lies in dissecting neurochemical pathways involved in sexual motivation, appetitive behavior, and central energy homeostasis. Researchers studying receptor crosstalk frequently evaluate PT-141 alongside other neuro-endocrine probes available in our expanded peptide research library to characterize GPCR signaling cascades in isolated neuronal cultures.

Reconstitution Mathematics for 2mg PT-141 Vials

Accurate reconstitution is essential for maintaining precise dosing metrics during in vitro and in vivo laboratory protocols. When reconstituting a 2mg vial of lyophilized PT-141, the concentration of the resulting solution depends directly on the volume of sterile diluent introduced into the vial. Standard laboratory diluents include 0.9% Bacteriostatic Water for Injection (containing 0.9% benzyl alcohol) or Sterile Normal Saline.

To achieve target working concentrations, researchers can utilize the following exact dilution ratios for a 2mg (2,000 mcg) total peptide mass:

1. Reconstitution with 1.0 mL Diluent: Yields a final concentration of 2.0 mg/mL (200 mcg per 0.1 mL or 100 U/mL standard volumetric scale). This higher concentration is optimal for micro-injection models or protocols requiring minimal liquid volume delivery.

2. Reconstitution with 2.0 mL Diluent: Yields a final concentration of 1.0 mg/mL (100 mcg per 0.1 mL). This 1:1 ratio simplifies volumetric calculations during bench administration and decreases pipetting variance across multi-well assays.

3. Reconstitution with 3.0 mL Diluent: Yields a final concentration of 0.67 mg/mL (66.7 mcg per 0.1 mL). This lower concentration is frequently selected when preparing extended concentration-response curves or conducting high-throughput in vitro binding screens.

For complex volumetric planning, multi-vial scaling, or custom diluent mixtures, bench technicians should consult our interactive reconstitution calculator to ensure accurate concentration verification prior to experimental application.

Aliquot Strategy, Storage Parameters & Stability Guidelines

Proper handling and temperature control are critical to maintaining the peptide bond integrity of PT-141. Upon receipt, un-reconstituted lyophilized vials should be stored at -20°C in a dry, dark environment to ensure shelf stability for up to 24 months. For long-term archiving exceeding two years, storage at -80°C is recommended to prevent auto-hydrolysis or oxidation.

Once reconstituted with bacteriostatic water, the solution should be stored at 2°C to 8°C (refrigerated) and used within 28 days. Avoid repeated freeze-thaw cycles, as cyclic ice crystal formation can sever peptide bonds, alter secondary structure, and lead to irreversible aggregation. If long-term storage of reconstituted PT-141 is required, the solution should be immediately aliquoted into sterile, low-binding polypropylene micro-centrifuge tubes at target working concentrations and maintained at -80°C.

When preparing aliquots, bench personnel should use filter-barrier pipette tips and sterile working fields to prevent microbial contamination. Preclinical studies indicate that exposure to direct light and elevated temperatures accelerates the breakdown of cyclic peptides; therefore, vials and aliquots must remain shielded in light-blocking storage boxes throughout experimental storage.

Vial Selection Strategy: Comparing 2mg vs 10mg Formulations

Choosing between a 2mg and 10mg vial size depends on the specific scale, duration, and volume requirements of your laboratory project. A 2mg vial provides targeted utility for pilot studies, single-dose pharmacokinetic assessments in rodent models, or initial cell culture titration assays where minimizing reconstitute age is paramount.

Conversely, laboratories running high-throughput screening, multi-cohort animal models, or continuous long-term signaling studies benefit significantly from larger fill sizes. PX1 Research supplies high-purity PT-141 10mg vials which offer greater volumetric efficiency, lower packaging overhead, and consistent lot continuity across extended research schedules.

For comparative context, the table below outlines key operational differences between typical 2mg and 10mg research vial formats:

Quality Verification: Mass Spectrometry, HPLC, and COA Standards

At PX1 Research, every batch of PT-141 undergoes rigorous analytical testing to verify chemical identity, structural integrity, and purity. We provide a downloadable, lot-matched Certificate of Analysis (COA) for every shipment, ensuring complete transparency and reproducibility for institutional research accounts.

Quality control protocols for PT-141 utilize two core analytical methodologies:

1. High-Performance Liquid Chromatography (HPLC): Evaluates peptide purity by separating structural isomers, truncated sequences, and residual synthesis side-products. PX1 guarantees a minimum HPLC purity of ≥98.0%, with standard production lots exceeding 99.0%.

2. Mass Spectrometry (MS): Confirms exact molecular weight (2,000.27 g/mol expected) and peptide identity through electrospray ionization mass spectrometry (ESI-MS), verifying the absence of sequence deletion mutations.

Additionally, all lots undergo Limulus Amebocyte Lysate (LAL) testing to confirm endotoxin levels remain strictly under <0.01 EU/mg, preventing confounding inflammatory responses in sensitive cell lines or rodent models. Institutional buyers seeking bulk lots or dedicated batch reservation can coordinate directly via our wholesale lab portal.

Comparative Analysis: PT-141 within Melanocortin Signaling Research

Within the broader field of neuro-endocrine research, PT-141 occupies a unique position compared to other melanocortin receptor agonists. Unlike non-selective ancestral compounds like Melanotan II (MT-2), which strongly bind MC1R to drive melanogenesis in dermal tissues, PT-141 exhibits enhanced selectivity for central MC3R and MC4R pathways.

In preclinical comparative studies, PT-141 demonstrates negligible binding affinity for MC1R at standard physiological working concentrations, significantly reducing peripheral skin pigmentation markers during animal trials. Furthermore, when contrasted with classical growth hormone secretagogues like CJC-1295 No DAC 2mg or somatostatin analogs, PT-141 operates entirely independently of the somatotropic axis, targeting central behavioral and autonomic output rather than systemic pituitary hormone secretion.

This distinct receptor selectivity profile makes PT-141 an indispensable probe for researchers isolating central hypothalamic signaling mechanisms without triggering systemic endocrine or dermal melanogenic side pathways.

Procurement, Compliance, and Lab Supply Infrastructure

PX1 Research operates dedicated manufacturing and fulfillment infrastructure within the USA, operating out of state-of-the-art facilities located in California and Arizona. All research peptides are synthesized under GMP-compliant protocols, ensuring batch-to-batch consistency and reliable supply continuity for academic, governmental, and private research institutions.

Orders placed before 12:00 PM PST Monday through Friday ship same-day, utilizing temperature-monitored, protective packaging designed to preserve peptide stability during transit. Whether ordering individual test units or establishing recurring institutional supply agreements through our wholesale program, researchers can rely on PX1 for fully verified, laboratory-grade compounds.

All materials supplied by PX1 Research—including PT-141 in 2mg or 10mg configurations—are strictly manufactured and sold for in vitro and laboratory research use only. They are explicitly not intended for human or veterinary clinical use, administration, therapy, or diagnostic applications.